Inactive Instrument

Press Releases Cangene Corporation

Equities

Cangene Corporation : 12/13/2013 Cangene Reports First Quarter 2014 Results and Election of Directors	14/13/14	PU
Cangene Corporation : 12/11/2013 Cangene To Be Acquired By Emergent BioSolutions For US$222 Million	12/13/12	PU
Cangene Corporation : FDA lifts clinical hold on Cangene's hemophilia compound IB1001	30/13/30	PU
Cangene Corporation : Cangene Reports Third Quarter 2013 Results	06/13/06	PU
Cangene Corp : Further Senior Management Change at Cangene	12/12/12	PU
Cangene Corp : Cangene Names John A. Sedor as President and Chief Executive Officer	17/11/17	PU
CANGENE : ANNOUNCES THIRD QUARTER FINANCIAL RESULTS FOR FISCAL 2011	14/11/14	PU
CANGENE : BARDA EXERCISES OPTIONS WITH CANGENE WORTH US$61 MILLION UNDER BOTULISM ANTITOXIN SUPPLY CONTRACT	04/11/04	PU

No results for this search